Published in Histopathology on September 01, 1997
Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. Am J Pathol (1999) 2.02
Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis. Am J Pathol (1999) 1.01
Cribriform-Morular Variant of Papillary Carcinoma: Association with Familial Adenomatous Polyposis - Report of Three Cases and Review of Literature. Int J Med Sci (2004) 0.85
Molecular evidence for multicentric development of thyroid carcinomas in patients with familial adenomatous polyposis. Am J Pathol (2000) 0.85
Gastrointestinal manifestations of endocrine disease. World J Gastroenterol (2006) 0.82
FAP Associated Papillary Thyroid Carcinoma: A Peculiar Subtype of Familial Nonmedullary Thyroid Cancer. Patholog Res Int (2015) 0.75
MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer (2006) 4.11
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell (1990) 3.98
Intolerance of cow's milk and chronic constipation in children. N Engl J Med (1998) 3.90
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene (2007) 3.29
Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science (1995) 2.83
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature (1987) 2.60
The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res (1999) 2.56
Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol (1999) 2.38
Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol (1995) 2.22
Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope (1997) 2.15
High level expression of the HMGI (Y) gene during embryonic development. Oncogene (1996) 2.13
Role of the high mobility group A proteins in human lipomas. Carcinogenesis (2001) 2.08
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res (1998) 2.00
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene (1989) 1.94
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Oncogene (1994) 1.87
Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues. Br J Cancer (2002) 1.87
Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev (2001) 1.85
Role of pancreatic impairment in growth recovery during gluten-free diet in childhood celiac disease. Gastroenterology (1997) 1.83
Sex hormones and risk of liver tumor. Ann N Y Acad Sci (2006) 1.77
Bile duct injuries during laparoscopic cholecystectomy: a 1994-2001 audit on 13,718 operations in the area of Rome. Surg Endosc (2003) 1.68
The RET receptor: function in development and dysfunction in congenital malformation. Trends Genet (2001) 1.67
The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene (1995) 1.61
Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp Cell Res (1989) 1.61
Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci U S A (2001) 1.60
Small thymus in very low birth weight infants born to mothers with subclinical chorioamnionitis. J Pediatr (1999) 1.59
Absence of the inferior labial and lingual frenula in Ehlers-Danlos syndrome. Lancet (2001) 1.58
Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. Oncogene (1997) 1.57
Endovascular treatment of a cavernous sinus dural arteriovenous fistula by transvenous embolisation through the superior ophthalmic vein via cannulation of a frontal vein. Neuroradiology (2003) 1.55
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. Liver Int (2006) 1.54
Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene (1998) 1.52
Clinical and pH-metric characteristics of gastro-oesophageal reflux secondary to cows' milk protein allergy. Arch Dis Child (1996) 1.52
The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene (1990) 1.52
Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J (1997) 1.51
Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc Natl Acad Sci U S A (2000) 1.47
Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc Natl Acad Sci U S A (1992) 1.46
Hypoplastic or absent mandibular frenulum: a new predictive sign of infantile hypertrophic pyloric stenosis. J Pediatr (2000) 1.46
Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia. Clin Radiol (2009) 1.45
Use of 24-hour oesophageal pH-metry for the detection of gastro-oesophageal reflux in infants: what is the ideal score and the optimal threshold? A receiver-operating-characteristic analysis. Ital J Gastroenterol Hepatol (1997) 1.42
Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab (2000) 1.39
Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene (1996) 1.39
[Evidence-based medicine: the emerging of a new model of clinical practice. Italian Group for Evidence-Based Medicine (GIMBE)]. Ann Ital Med Int (1997) 1.38
Prevalence of biliary lithiasis in a Sicilian population of hemodialysis patients. Clin Nephrol (2001) 1.38
Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res (1996) 1.37
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab (1999) 1.37
Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells. J Clin Invest (1999) 1.30
Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers. Cancer (1994) 1.30
Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res (1998) 1.29
Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol Cell Biol (2001) 1.29
5-Aza-2'-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias. Blood (1984) 1.27
Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res (1985) 1.27
The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Res (1998) 1.27
Serum levels of pancreatitis-associated protein as indicators of the course of acute pancreatitis. Multicentric Study Group on Acute Pancreatitis. Gastroenterology (1994) 1.26
Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. Mol Cell Biol (2001) 1.26
Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene (2010) 1.25
Block in the expression of differentiation markers of rat thyroid epithelial cells by transformation with Kirsten murine sarcoma virus. Cancer Res (1982) 1.25
Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1). Mol Cell Biol (2000) 1.24
Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. Cancer Res (2000) 1.24
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer (2008) 1.22
Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res (1994) 1.22
An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue. Br J Cancer (2003) 1.20
Multiple mechanisms of interference between transformation and differentiation in thyroid cells. Mol Cell Biol (1992) 1.19
Thyroid cancer and the Chernobyl accident. Are long-term and long distance side effects of fall-out radiation greater than estimated? J Clin Endocrinol Metab (1997) 1.19
RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene (1995) 1.19
Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res (1998) 1.18
Partial amino acid sequence of human pancreatic stone protein, a novel pancreatic secretory protein. Biochem J (1986) 1.18
RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol (2000) 1.17
The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. Cell Growth Differ (1993) 1.17
PATZ1 gene has a critical role in the spermatogenesis and testicular tumours. J Pathol (2008) 1.17
Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential. Diabetes Metab Res Rev (2001) 1.17
The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. J Clin Endocrinol Metab (1998) 1.17
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. Br J Cancer (2005) 1.17
A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor. J Biol Chem (2000) 1.16
PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1. Oncogene (2000) 1.15
High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene (2001) 1.15
Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1994) 1.14
A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern. J Virol (1985) 1.14
Transformation of thyroid epithelium is associated with loss of c-kit receptor. Cancer Res (1995) 1.13
Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker. Cancer Res (1999) 1.11
Lactose intolerance and self-reported milk intolerance: relationship with lactose maldigestion and nutrient intake. Lactase Deficiency Study Group. J Am Coll Nutr (1998) 1.10
Why do patients with cerebellar ataxia not use environmental cues for reducing unpredictability of sudden gait stopping? Cerebellum (2013) 1.10
Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am J Pathol (1999) 1.10
FRA-1 expression in hyperplastic and neoplastic thyroid diseases. Clin Cancer Res (2000) 1.10
Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-selectin in normotensive and hypertensive patients. Hypertension (1997) 1.07
Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC. Oncogene (1991) 1.07
An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway. Mol Cell Biol (1994) 1.07
Analysis of the myeloproliferative sarcoma virus genome: limited changes in the prototype lead to altered target cell specificity. J Virol (1981) 1.07
Exocrine pancreatic function in children with coeliac disease before and after a gluten free diet. Gut (1991) 1.07
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. Oncogene (2006) 1.07
Walking there: environmental influence on walking-distance estimation. Behav Brain Res (2011) 1.07
The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A). Oncogene (1989) 1.07
Use of ass' milk in multiple food allergy. J Pediatr Gastroenterol Nutr (1992) 1.07
Thymosin beta-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. Cancer Res (1998) 1.07
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival. Cancer Res (2000) 1.06
Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors. Cell Growth Differ (1998) 1.06
Transformation of mononuclear phagocytes in vivo and malignant histiocytosis caused by a novel murine spleen focus-forming virus. Nature (1985) 1.06